Disciplined Growth Investors Inc Cara Therapeutics, Inc. Transaction History

Disciplined Growth Investors Inc

  • $5.44 Billion
  • Q1 2024

A detailed history of Disciplined Growth Investors Inc transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Disciplined Growth Investors Inc holds 1,815,058 shares of CARA stock, worth $598,969. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,815,058
Previous 1,812,100 0.16%
Holding current value
$598,969
Previous $1.34 Million 23.21%
% of portfolio
0.03%
Previous 0.03%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$0.52 - $1.05 $1,538 - $3,105
2,958 Added 0.16%
1,815,058 $1.65 Million
Q4 2023

Feb 14, 2024
BUY
$0.6 - $1.65 $23,821 - $65,509
39,703 Added 2.24%
1,812,100 $1.34 Million
Q3 2023

Nov 14, 2023
BUY
$1.67 - $3.33 $13,687 - $27,292
8,196 Added 0.46%
1,772,397 $2.98 Million
Q2 2023

Aug 14, 2023
BUY
$2.83 - $4.94 $90,067 - $157,220
31,826 Added 1.84%
1,764,201 $4.99 Million
Q1 2023

May 15, 2023
BUY
$4.89 - $12.27 $48,577 - $121,890
9,934 Added 0.58%
1,732,375 $8.51 Million
Q4 2022

Feb 14, 2023
BUY
$8.88 - $12.77 $197,233 - $283,634
22,211 Added 1.31%
1,722,441 $18.5 Million
Q3 2022

Nov 15, 2022
BUY
$8.24 - $12.56 $11,601 - $17,684
1,408 Added 0.08%
1,700,230 $15.9 Million
Q2 2022

Aug 15, 2022
BUY
$7.45 - $13.84 $33,316 - $61,892
4,472 Added 0.26%
1,698,822 $15.5 Million
Q1 2022

May 16, 2022
BUY
$9.94 - $12.65 $372,640 - $474,235
37,489 Added 2.26%
1,694,350 $20.6 Million
Q4 2021

Feb 14, 2022
SELL
$11.99 - $18.14 $146,613 - $221,815
-12,228 Reduced 0.73%
1,656,861 $20.2 Million
Q3 2021

Nov 15, 2021
BUY
$11.55 - $16.06 $11.5 Million - $16 Million
994,243 Added 147.33%
1,669,089 $25.8 Million
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $1.01 Million - $2.37 Million
81,363 Added 13.71%
674,846 $9.63 Million
Q1 2021

May 17, 2021
SELL
$15.07 - $21.71 $1.45 Million - $2.09 Million
-96,416 Reduced 13.98%
593,483 $12.9 Million
Q4 2020

Feb 16, 2021
SELL
$12.72 - $16.16 $552,658 - $702,119
-43,448 Reduced 5.92%
689,899 $10.4 Million
Q3 2020

Nov 16, 2020
BUY
$12.34 - $17.92 $12,340 - $17,920
1,000 Added 0.14%
733,347 $9.33 Million
Q2 2020

Aug 14, 2020
SELL
$12.39 - $17.33 $299,726 - $419,230
-24,191 Reduced 3.2%
732,347 $12.5 Million
Q1 2020

May 15, 2020
SELL
$9.12 - $17.78 $751,269 - $1.46 Million
-82,376 Reduced 9.82%
756,538 $9.99 Million
Q4 2019

Feb 14, 2020
BUY
$16.11 - $25.98 $853 - $1,376
53 Added 0.01%
838,914 $13.5 Million
Q3 2019

Nov 15, 2019
BUY
$18.28 - $26.91 $10,657 - $15,688
583 Added 0.07%
838,861 $15.3 Million
Q2 2019

Aug 14, 2019
SELL
$17.68 - $21.57 $258,375 - $315,223
-14,614 Reduced 1.71%
838,278 $18 Million
Q1 2019

May 14, 2019
BUY
$14.41 - $19.64 $79,384 - $108,196
5,509 Added 0.65%
852,892 $16.7 Million
Q4 2018

Feb 13, 2019
SELL
$12.45 - $23.47 $28,622 - $53,957
-2,299 Reduced 0.27%
847,383 $11 Million
Q3 2018

Nov 16, 2018
SELL
$17.57 - $23.95 $151,189 - $206,089
-8,605 Reduced 1.0%
849,682 $20.4 Million
Q2 2018

Aug 15, 2018
SELL
$11.6 - $19.27 $14,824 - $24,627
-1,278 Reduced 0.15%
858,287 $16.4 Million
Q1 2018

May 17, 2018
SELL
$11.77 - $16.08 $19,467 - $26,596
-1,654 Reduced 0.19%
859,565 $10.6 Million
Q4 2017

Feb 15, 2018
BUY
$11.86 - $14.08 $143,138 - $169,931
12,069 Added 1.42%
861,219 $10.5 Million
Q3 2017

Nov 14, 2017
BUY
$12.6 - $16.34 $10.7 Million - $13.9 Million
849,150
849,150 $11.6 Million

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $17.7M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Disciplined Growth Investors Inc Portfolio

Follow Disciplined Growth Investors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Disciplined Growth Investors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Disciplined Growth Investors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email